NovaBay Pharmaceuticals to Present at the 7th Annual LD Micro Invitational

NovaBay Pharmaceuticals to Present at the 7 ^th Annual LD Micro Invitational

NovaBay^® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova^® lid and lash hygiene for the domestic eye care market, announces that management is scheduled to present a corporate overview at the 7^th Annual LD Micro Invitational Conference on Tuesday, June 6, 2017, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time). The conference is being held at Luxe Sunset Boulevard Hotel in Los Angeles.

A live webcast and replay will be available on the Investors section of the Company's website at http://novabay.com/investors/events.

About NovaBay Pharmaceuticals, Inc.: Going Beyond Antibiotics ^®

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focusing on commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global, topical anti-infective market with its two distinct product categories: the NEUTROX^® family of products and the AGANOCIDE^® compounds. The Neutrox family of products includes AVENOVA^® for the eye care market, NEUTROPHASE^® for the wound care market, and CELLERX^® for the aesthetic dermatology market. The Aganocide compounds, still under development, have target applications in the dermatology and urology markets.

Stay informed on NovaBay's progress:
Download our Mobile InvestorApp from the  Apple Store  or  Google Play
Like us on Facebook
Follow us on Twitter
Connect with NovaBay on LinkedIn
Join us on Google+
Visit NovaBay's Website

NovaBay Contacts
For NovaBay Avenova purchasing information, please contact:
Email us
Call us: 1-800-890-0329
www.Avenova.com
or
From the Company
Thomas J. Paulson
Chief Financial Officer
510-899-8809
Contact Tom
or
Investor Contact:
LHA
Jody Cain
310-691-7100
Jcain@lhai.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20170530005242/en/